{"articles":[{
"contentID": "1772319",
"articleURL": "/news/articles/research-groups/tate-group/2026/new-senolytic-strategy-targets-a-key-vulnerability-in-ageing-cells/",
"date": "29 April 2026",
"year": "2026",
"sortDate": "2026-04-29",
"headline": "New senolytic strategy targets a key vulnerability in ageing cells",
"summary": "We report the discovery of a new way to selectively eliminate senescent cells by targeting their dependence on the antioxidant enzyme GPX4.",
"image": "",
"author": "Eve Carter",
"profile": "Professor Ed W Tate",
"homepage": "",
"owningGroup": "Natural Sciences, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Cancer|Drug Discovery|Research",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1770890",
"articleURL": "/news/articles/research-groups/tate-group/2026/dr-jana-volaric-win-best-poster-prize-at-the-international-symposium-on-photopharmacology-2026/",
"date": "14 April 2026",
"year": "2026",
"sortDate": "2026-04-14",
"headline": "Dr Jana Volaric wins Best Poster Prize at the International Symposium on Photopharmacology 2026",
"summary": "Dr Jana Volaric received the best poster prize at the 5th International Symposium on Photopharmacology 2026.",
"image": "",
"author": "Eve Carter",
"profile": "",
"homepage": "",
"owningGroup": "Natural Sciences, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1772094",
"articleURL": "/news/articles/research-groups/tate-group/2026/broadening-the-molecular-glue-landscape/",
"date": "7 April 2026",
"year": "2026",
"sortDate": "2026-04-07",
"headline": "Broadening the molecular glue landscape",
"summary": "Our latest Nature Chemical Biology News & Views article\u00A0highlights new strategies that could expand the discovery of molecular glues for targeted protein degradation.",
"image": "",
"author": "Eve Carter",
"profile": "Professor Ed W Tate",
"homepage": "",
"owningGroup": "Natural Sciences, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery|Research",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1766046",
"articleURL": "/news/articles/research-groups/vilar-group/2026/platinum-based-phosphorescent-lifetime-probes-for-the-visualisation-of-g-quadrup/",
"date": "31 March 2026",
"year": "2026",
"sortDate": "2026-03-31",
"headline": "Platinum-based phosphorescent lifetime probes for the visualisation of G-quadruplex DNA in cells ",
"summary": "The use of Phosphorescence Lifetime Imaging Microscopy (PLIM) to visualise G-quadruplexes in live and fixed cells using a novel PLIM probe.",
"image": "",
"author": "Nicole Fitikides",
"profile": "Professor Ramon Vilar Compte",
"homepage": "",
"owningGroup": "Natural Sciences, Vilar Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery|Imaging|Molecular Sciences",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1758970",
"articleURL": "/news/articles/2026/scientists-find-promising-drug-target-for-tuberculosis/",
"date": "17 March 2026",
"year": "2026",
"sortDate": "2026-03-17",
"headline": "Scientists find promising drug target for tuberculosis",
"summary": "Researchers from Imperial and the London School of Hygiene & Tropical Medicine (LSHTM) have discovered a drug target that could potentially help tackle drug-resistant tuberculosis, one of the biggest causes of death worldwide.",
"image": "",
"author": "David Silverman",
"profile": "",
"homepage": "",
"owningGroup": "Imperial News, Natural Sciences, News, Chemistry, Life Sciences",
"topic": "Science, Health",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Bacteria|Drug Discovery|Enterprise|Infectious Diseases|Translation",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1759700",
"articleURL": "/news/articles/2026/new-centre-from-gsk-imperial-and-oxford-will-create-computer-models-of-lungs-liver-and-kidneys/",
"date": "13 March 2026",
"year": "2026",
"sortDate": "2026-03-13",
"headline": "New centre from Imperial, Oxford and GSK will build digital twins of lungs, liver and kidneys",
"summary": "A new research hub will create open-source computer models of organs to help accelerate the development of new medicines.\n",
"image": "",
"author": "David Silverman",
"profile": "",
"homepage": "",
"owningGroup": "News",
"topic": "Health",
"topicLabel": "Health",
"storyType": "News Article",
"tags": "Artificial Intelligence|Drug Discovery|Enterprise|Healthcare",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1770899",
"articleURL": "/news/articles/research-groups/tate-group/2026/sofia-srdanovic-wins-poster-prize-at-2026-rsc-cbbg/",
"date": "7 March 2026",
"year": "2026",
"sortDate": "2026-03-07",
"headline": "Sofia Srdanovic wins poster prize at 2026 RSC CBBG",
"summary": "Sofia Srdanovic was awarded a poster prize at 2026 RSC Chemical Biology and Bioorganic Group Forum",
"image": "",
"author": "Eve Carter",
"profile": "",
"homepage": "",
"owningGroup": "Centres, Natural Sciences, Institute of Chemical Biology, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery|Research",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1770904",
"articleURL": "/news/articles/research-groups/tate-group/2026/designing-the-next-generation-of-molecular-glues/",
"date": "1 February 2026",
"year": "2026",
"sortDate": "2026-02-01",
"headline": "Designing the next generation of molecular glues",
"summary": "We discuss how molecular glue discovery is shifting from serendipitous findings to a more rational strategy for drug discovery.",
"image": "",
"author": "Eve Carter",
"profile": "Professor Ed W Tate",
"homepage": "",
"owningGroup": "Natural Sciences, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery|Research",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1756944",
"articleURL": "/news/articles/research-groups/tate-group/2026/congratulations-matt/",
"date": "28 January 2026",
"year": "2026",
"sortDate": "2026-01-28",
"headline": "Congratulations Matt!",
"summary": "Matt successfully defended his thesis, completing his PhD in the Tate group",
"image": "",
"author": "Edward Bartlett",
"profile": "",
"homepage": "",
"owningGroup": "Natural Sciences, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1736257",
"articleURL": "/news/articles/medicine/2026/new-vaccines-new-hope-first-human-trial-for-ebola-marburg-and-lassa-vaccines/",
"date": "19 January 2026",
"year": "2026",
"sortDate": "2026-01-19",
"headline": "New vaccines, new hope: First human trial for Ebola, Marburg and Lassa vaccines",
"summary": "A new research partnership will test cutting-edge vaccines designed to protect against some of the world\u2019s most dangerous infectious diseases.",
"image": "",
"author": "Louisa Lee",
"profile": "",
"homepage": "",
"owningGroup": "Medicine, News, Department of Infectious Disease",
"topic": "Health, Science",
"topicLabel": "Health",
"storyType": "News Article",
"tags": "Africa|Drug Discovery|Global Health|Healthcare|Infectious Diseases|Public Health|Vaccines",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1721160",
"articleURL": "/news/articles/research-groups/the-barnard-group/2026/new-publication-in-nature-communications/",
"date": "5 January 2026",
"year": "2026",
"sortDate": "2026-01-05",
"headline": "New publication in Nature Communications",
"summary": "Our latest work using peptide tools to understand DNA replication is out in Nature Communications",
"image": "",
"author": "Anna Barnard",
"profile": "Dr Anna Barnard",
"homepage": "",
"owningGroup": "Natural Sciences, Barnard Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Cancer|Drug Discovery|Research",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1771527",
"articleURL": "/news/articles/research-groups/tate-group/2026/raspi3k-pathway-mutations-sensitise-cancer-cells-to-a-parpnampt-inhibitor-combination/",
"date": "19 December 2025",
"year": "2025",
"sortDate": "2025-12-19",
"headline": "RAS\/PI3K pathway mutations sensitise cancer cells to a PARP\/NAMPT inhibitor combination",
"summary": "Ovarian cancer cells with RAS\/PI3K pathway mutations have chronically low NAD\u207A levels, making them highly vulnerable to a dual\u2011therapy strategy that combines PARP inhibition (olaparib) with NAMPT inhibition (FK866)",
"image": "",
"author": "Edward Bartlett",
"profile": "",
"homepage": "",
"owningGroup": "Natural Sciences, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1756935",
"articleURL": "/news/articles/research-groups/tate-group/2026/congratulations-thomas/",
"date": "12 December 2025",
"year": "2025",
"sortDate": "2025-12-12",
"headline": "Congratulations Thomas!",
"summary": "Thomas successfully defended his thesis, completing his PhD in the Tate group",
"image": "",
"author": "Edward Bartlett",
"profile": "",
"homepage": "",
"owningGroup": "Natural Sciences, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1710941",
"articleURL": "/news/articles/2025/gsk-and-fleming-initiative-scientists-unite-to-target-amr-with-advanced-ai/",
"date": "18 November 2025",
"year": "2025",
"sortDate": "2025-11-18",
"headline": "GSK and Fleming Initiative scientists unite to target AMR with advanced AI ",
"summary": "\u00A345m in GSK funding has been allocated to new research programmes combining expertise and using cutting edge AI technology to accelerate AMR research.",
"image": "",
"author": "Ryan O'Hare",
"profile": "Professor Lord Ara Darzi",
"homepage": "",
"owningGroup": "Medicine, Natural Sciences, News, Centre for Bacterial Resistance Biology, Department of Infectious Disease, Vilar Group",
"topic": "Health",
"topicLabel": "Health",
"storyType": "News Article",
"tags": "Antibiotics|Artificial Intelligence|Bacteria|Drug Discovery|Industry|Viruses",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1764502",
"articleURL": "/news/articles/2025/pfizer-metsera/",
"date": "16 November 2025",
"year": "2025",
"sortDate": "2025-11-16",
"headline": "Pfizer wraps up $10bn deal for Imperial obesity drug candidates ",
"summary": "Global drugmaker wins race for candidates invented by GLP-1 pioneer Professor Steve Bloom, positioning it to lead the way in next-generation obesity treatments.",
"image": "",
"author": "David Silverman",
"profile": "Professor Steve R Bloom, Dr Mike Romanos",
"homepage": "yes",
"owningGroup": "Imperial News, Medicine, News, Department of Metabolism Digestion and Reproduction",
"topic": "Health",
"topicLabel": "Health",
"storyType": "News Article",
"tags": "Drug Discovery|Enterprise|White City Incubator",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1699622",
"articleURL": "/news/articles/medicine/department-of-surgery-and-cancer-news-articles/2025/spp1-a-new-drug-target-to-stop-the-deadly-spread-of-pancreatic-cancer/",
"date": "8 October 2025",
"year": "2025",
"sortDate": "2025-10-08",
"headline": "SPP1: A new drug target to stop the deadly spread of pancreatic cancer",
"summary": "Researchers have identified a new potential drug target to treat & stop the spread of one of the most aggressive & common types of pancreatic cancer.",
"image": "",
"author": "Benjie Coleman",
"profile": "Professor Axel J Behrens",
"homepage": "",
"owningGroup": "Medicine, Department of Surgery and Cancer",
"topic": "Health",
"topicLabel": "Health",
"storyType": "News Article",
"tags": "Cancer|Drug Discovery",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1699573",
"articleURL": "/news/articles/medicine/metabolism-digestion-reproduction/2025/pfizer-aims-to-bring-imperial-obesity-drug-candidates-to-clinic-in-49bn-deal/",
"date": "8 October 2025",
"year": "2025",
"sortDate": "2025-10-08",
"headline": "Pfizer aims to bring Imperial obesity drug candidates to clinic in $4.9bn deal",
"summary": "Multinational bets on candidates invented by GLP-1 pioneer Professor Steve Bloom to propel it into the race for next-generation obesity treatments.",
"image": "",
"author": "David Silverman",
"profile": "Professor Steve R Bloom, Dr Mike Romanos",
"homepage": "yes",
"owningGroup": "Medicine, Department of Metabolism Digestion and Reproduction",
"topic": "Health",
"topicLabel": "Health",
"storyType": "News Article",
"tags": "Drug Discovery|Enterprise|White City Incubator",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1765079",
"articleURL": "/news/articles/research-groups/tate-group/2026/best-poster-at-efmc-asmc-2025/",
"date": "1 October 2025",
"year": "2025",
"sortDate": "2025-10-01",
"headline": "Dr. Efthymios S. Gavriil wins Best Poster prize at EFMC-ASMC 2025",
"summary": "Dr. Efthymios S. Gavriil received the best poster prize at the 10th edition of the European Federation for Medicinal Chemistry and Chemical Biology International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC 2025).",
"image": "",
"author": "Edward Bartlett",
"profile": "",
"homepage": "",
"owningGroup": "Natural Sciences, Tate Group",
"topic": "Science",
"topicLabel": "Science",
"storyType": "News Article",
"tags": "Drug Discovery",
"ratio": "1.50",
"visible": "yes"
},{
"contentID": "1703876",
"articleURL": "/news/articles/research-groups/covid19-human-challenge-study-covhic002/2024/imperials-human-challenge-study-helps-explain-why-some-people-dont-get-covid/",
"date": "19 June 2024",
"year": "2024",
"sortDate": "2024-06-19",
"headline": "Imperial\u2019s human challenge study helps explain why some people don\u2019t get COVID",
"summary": "New analysis based on Imperial\u2019s COVID-19 human challenge study has helped to uncover how some people avoid getting sick.",
"image": "",
"author": "Ryan O'Hare",
"profile": "Professor Christopher Chiu",
"homepage": "",
"owningGroup": "Medicine, Department of Infectious Disease",
"topic": "Health",
"topicLabel": "Health",
"storyType": "News Article",
"tags": "Drug Discovery|Infectious Diseases|Research",
"ratio": "1.50",
"visible": "yes"
},]}
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/Matt-paper.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/IMG-1012-(1).jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/Janine-paper.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/2026-03-31-Pt-PLIM-G4-TOC(1).jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/tb.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/mimec.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/processed-46C6F3C6-09D9-4C10-94AB-5ECD39653324.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/janine.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/images/landscape-3000X2000/matt-viva-3000-x-2000.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/EML-Vac-19012026.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/Geminin-Cdt1-figure_news-copy.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/images/landscape-3000X2000/Picture1-3200-2000-(2).jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/images/landscape-3000X2000/thomas-viva-3000-x-2000.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/2025-11-18-Fleming-AMR-Andrew-Edwards.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/professor-steve-bloom.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/pancreatic-cancer.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/images/landscape-3000X2000/esg-3000-2000.jpg\")
![\"\"](\"https://pxl01-imperialacuk.terminalfour.net/fit-in/540x360/prod01/channel_4/imperial-news/media/news-images/3000X2000-main-article-images/2024-6-19-COVID-19-human-challenge-study.jpg\")